Table 1.
Patient | Breed/sex | Age (y) | Tumor type/grade | Survival (d)b | No. CED infusions | Cause of death |
---|---|---|---|---|---|---|
1 | Jack Russell terrier FS | 9 | Astrocytoma II/IIIa | +331 | 3 | Euthanasia (hemangiosarcoma)c |
2 | Boxer M | 8 | Astrocytoma II/IIIa | +560 | 6 | Euthanasia (tumor progression) |
3 | French bulldog FS | 10 | Astrocytoma II/IIIa | +363 | 3 | Euthanasia (tumor progression) |
4 | Labrador MC | 10 | Astrocytoma II | +190 | 3 | Euthanasia (pancreatitis)c |
5 | Boston terrier MC | 6 | Oligodendroglioma II | +126 | 1 | Died (status epilepticus)c |
6 | Boxer MC | 7 | Oligodendroglioma III | +147 | 2 | Euthanasia (tumor progression) |
7 | English bulldog MC | 5 | Oligodendroglioma III | +190 | 3 | Euthanasia (tumor progression) |
8 | Labrador FS | 14 | Oligodendroglioma II | +611 | 3 | Alive |
9 | Boston terrier M | 6 | Oligodendroglioma III | +181 | 2 | Alive |
aInitial grade based on streotactic/CT biopsy; final grade based on necropsy.
bSurvival was determined from the time of initial MRI diagnosis.
cCause of death was determined to be unrelated to tumor progression.